Trial Profile
Evaluation of preference for a buprenorphine-based maintenance therapy, after a switch from buprenorphine alone (Subutex) to the buprenorphine/naloxone combination (Suboxone), in opioid-dependent patients with buprenorphine maintenance therapy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Mar 2023
Price :
$35
*
At a glance
- Drugs Buprenorphine/naloxone (Primary) ; Buprenorphine
- Indications Pain
- Focus Therapeutic Use
- Acronyms COMPLETED
- Sponsors Reckitt Benckiser; Schering-Plough
- 22 Jul 2011 New trial record